That compares with up to 16% from Novo Nordisk’s Wegovy, and up to 22.5% from Eli Lilly’s rival Mounjaro when administered alongside lifestyle interventions such as improved diet, exercise and sleep.

Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has ...

Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...

FRANKFURT (Reuters) - Healthcare executives and investors expect an uptick in initial public offerings and corporate ...

Lilly and Novo Nordisk are hoping to win over employers on the idea that obesity and its complications are already a huge cost in terms of healthcare, workers' compensation and disability. By offering ...

There’s no hard-and-fast rule for how long it’s safe to stay on Ozempic for weight loss. Novo Nordisk-sponsored studies lasting up to two years show that semaglutide is safe.

In a study by the Northwestern Medicine Canning Thoracic Institute in Chicago, the RNA in the SARS-CoV-2 virus was found to "trigger the development of a unique type of immune cell with anti-cancer ...

It is an unconventional approach for pharmaceutical companies. (Lofus, 11/19) Bloomberg: Novo Nordisk Launches Wegovy In China With Prices Below US Novo Nordisk A/S is launching its top-selling Wegovy ...

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...